Business Context and Reporting Period
This Form 8-K filing by Sintx Technologies, Inc. (Delaware) was submitted on February 19, 2019, reporting an event that occurred on February 13, 2019. The Company is a biotechnology firm headquartered in Salt Lake City, Utah.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding stock listing requirements.
Material Changes
The primary material event is the Company's failure to regain compliance with NASDAQ's $1.00 minimum bid price requirement during the initial 180-day grace period. Consequently, the Company has been granted an additional 180-day grace period, extending until August 12, 2019, to cure the deficiency.
Outlook, Management Commentary, and Risks
- Compliance Strategy: Management has notified NASDAQ of its intention to cure the bid price deficiency during the second compliance period, potentially by effecting a reverse stock split.
- Eligibility: The Company remains eligible for the extension because it meets the market value of publicly held shares requirement and all other initial listing requirements for the Nasdaq Capital Market, with the exception of the bid price.
- Risk: Failure to regain compliance by August 12, 2019, could result in delisting from the NASDAQ Stock Market.
Investor Verification Checklist
- Verify the current trading price of Sintx Technologies stock to assess the likelihood of meeting the $1.00 minimum bid requirement.
- Monitor upcoming shareholder meetings or press releases for a formal proposal of a reverse stock split.
- Confirm the Company's continued compliance with the market value of publicly held shares requirement.
- Review the August 12, 2019 deadline for potential delisting notices if compliance is not achieved.